Eidos Therapeutics, Inc.
SEC CIK 1731831 · EIDX · last insider filing 2021-01-28
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Rohlen Duke | Director | filed 2020 - 2021 |
| Hooper Suzanne Sawochka | Director | filed 2020 - 2021 |
| Lis William | Director | filed 2018 - 2021 |
| Satvat Ali J. | Director | filed 2018 - 2021 |
| Sinha Uma | Director · Chief Scientific Officer | filed 2018 - 2021 |
| Aguiar Eric | Director | filed 2018 - 2020 |
| Shah Rajeev M. | Director | filed 2018 - 2020 |
| Kumar Neil | Director · Chief Executive Officer | filed 2018 - 2019 |
| RA Capital Healthcare Fund LP | Director | filed 2018 - 2018 |
| RA Capital Management, LLC | Director | filed 2018 - 2018 |
| Kolchinsky Peter | Director | filed 2018 - 2018 |
| Huh Hoyoung | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Fox Jonathan C | See Remarks | filed 2018 - 2021 |
| Valle Franco | Senior Vice President, Finance | filed 2020 - 2021 |
| Turtle Cameron | Chief Business Officer | filed 2018 - 2021 |
| Siu Christine | See Remarks | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.